Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
J Virol
; 97(11): e0144823, 2023 Nov 30.
Article
in En
| MEDLINE
| ID: mdl-37855638
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Single-Domain Antibodies
/
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Year:
2023
Type:
Article